Original Contributions |
From the Departments of Pathology II (W.L., X.M.Y., U.T.B.), Internal Medicine (W.L., X.M.Y., A.G.O.), and Clinical Research Centre (W.L., X.M.Y., A.G.O.), Faculty of Health Sciences, University of Linköping, Sweden.
Correspondence to Dr W. Li, Department of Pathology II, University Hospital, S-581 85 Linköping, Sweden. E-mail weili{at}pat.liu.se
AbstractThe cytotoxicity of oxidized LDL (oxLDL) to several types of artery wall cells might contribute to atherosclerosis by causing cell death, presumably by both apoptosis and necrosis. After its uptake into macrophage lysosomes by receptor-mediated endocytosis, oxLDL is poorly degraded, resulting in ceroid-containing foam cells. We studied the influence of oxLDL on lysosomal enzyme activity and, in particular, on lysosomal membrane stability and the modulation of these cellular characteristics by HDL and vitamin E (vit-E). Unexposed cells and cells exposed to acetylated LDL (AcLDL) were used as controls. The lysosomal marker enzymes cathepsin L and N-acetyl-ß-glucosaminidase (NAßGase) were biochemically assayed in J-774 cells after fractionation. Lysosomal integrity in living cells was assayed by the acridine orange (AO) relocation test. Cathepsin D was immunocytochemically demonstrated in J-774 cells and human monocyte-derived macrophages. We found that the total activities of NAßGase and cathepsin L were significantly decreased, whereas their relative cytosolic activities were enhanced, after oxLDL exposure. Labilization of the lysosomal membranes was further proven by decreased lysosomal AO uptake and relocation to the cytosol of cathepsin D, as estimated by light and electron microscopic immunocytochemistry. HDL and vit-E diminished the cytotoxicity of oxLDL by decreasing the lysosomal damage. The results indicate that endocytosed oxLDL not only partially inactivates lysosomal enzymes but also destabilizes the acidic vacuolar compartment, causing relocation of lysosomal enzymes to the cytosol. Exposure to AcLDL resulted in its uptake with enlargement of the lysosomal apparatus, but the stability of the lysosomal membranes was not changed.
Key Words: atherosclerosis lysosomes macrophages oxidized LDL antioxidants
This article has been cited by other articles:
![]() |
R. de Nooijer, I. Bot, J.H. von der Thusen, M.A. Leeuwenburgh, H.S. Overkleeft, A.O. Kraaijeveld, R. Dorland, P.J. van Santbrink, S.H. van Heiningen, M.M. Westra, et al. Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 188 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Gerry and D. S. Leake A moderate reduction in extracellular pH protects macrophages against apoptosis induced by oxidized low density lipoprotein J. Lipid Res., April 1, 2008; 49(4): 782 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hamel, E. Abed, L. Brissette, and R. Moreau Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1021 - C1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J, October 1, 2007; 21(12): 3029 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Emert-Sedlak, S. Shangary, A. Rabinovitz, M. B. Miranda, S. M. Delach, and D. E. Johnson Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death Mol. Cancer Ther., May 1, 2005; 4(5): 733 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Fach, L.-A. Garulacan, J. Gao, Q. Xiao, S. M. Storm, Y. P. Dubaquie, S. A. Hefta, and G. J. Opiteck In Vitro Biomarker Discovery for Atherosclerosis by Proteomics Mol. Cell. Proteomics, December 1, 2004; 3(12): 1200 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, G. K. Sukhova, J.-S. Sun, W.-H. Xu, P. Libby, and G.-P. Shi Lysosomal Cysteine Proteases in Atherosclerosis Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Q. Nhan, W. C. Liles, A. Chait, J. T. Fallon, and S. M. Schwartz The p17 Cleaved Form of Caspase-3 Is Present Within Viable Macrophages In Vitro and in Atherosclerotic Plaque Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawai, A. Saito, N. Shibata, M. Kobayashi, S. Yamada, T. Osawa, and K. Uchida Covalent Binding of Oxidized Cholesteryl Esters to Protein: IMPLICATIONS FOR OXIDATIVE MODIFICATION OF LOW DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS J. Biol. Chem., May 30, 2003; 278(23): 21040 - 21049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jormsjo, D. M. Wuttge, A. Sirsjo, C. Whatling, A. Hamsten, S. Stemme, and P. Eriksson Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice Am. J. Pathol., September 1, 2002; 161(3): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuroyanagi, M. Nishimura, and I. Hara-Nishimura Activation of Arabidopsis Vacuolar Processing Enzyme by Self-Catalytic Removal of an Auto-Inhibitory Domain of the C-Terminal Propeptide Plant Cell Physiol., February 1, 2002; 43(2): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Salehi, B.-G. Fan, M. Ekelund, G. Nordin, and I. Lundquist TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E171 - E179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karten, H. Boechzelt, P. M. Abuja, M. Mittelbach, and W. Sattler Macrophage-enhanced formation of cholesteryl ester–core aldehydes during oxidation of low density lipoprotein J. Lipid Res., July 1, 1999; 40(7): 1240 - 1253. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |